Tricoci, Pierluigi <br/><br/>
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.  [electronic resource] 

 -  The New England journal of medicine  Jan 2012 
 - 20-33 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1109719  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Aged<br/>Angioplasty<br/>Cardiovascular Diseases--mortality<br/>Combined Modality Therapy<br/>Coronary Artery Bypass<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Hemorrhage--chemically induced<br/>Humans<br/>Intracranial Hemorrhages--chemically induced<br/>Kaplan-Meier Estimate<br/>Lactones--adverse effects<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Pyridines--adverse effects